• 中国上海
  • 400-682-1088
  • services@fanyibase.com
  • 客户案例

    研报中文原文

    研报中文原文

    期待估值切换,关注处方药及低估值个股——2013年1-8月医药行业分子行业数据解析投资...

    read more
    金隅股份研报qy288千赢国际

    金隅股份研报qy288千赢国际

    Comments on BBMG (601992) – underestimated PE, upgraded to “Buy”?Ove...

    read more
    中工国际研报qy288千赢国际

    中工国际研报qy288千赢国际

    China CAMC (002051) – revising down 2013 earnings forecast on lackluster 3Q13 results 3Q13 earnings rose 13 1%,

    read more
    上市公司研报qy288千赢国际案例-医药行业

    上市公司研报qy288千赢国际案例-医药行业

    Analysis of data on pharmaceutical sub-sectors in Jan-Aug 2013 – expecting roll-over to 2014 PE and watching the

    read more
    证券行业研究报告qy288千赢国际

    证券行业研究报告qy288千赢国际

    Preview of 3Q13 results of the securities sector –revenue up 20% and earnings up 30% in the first three quarte

    read more
    金融行业qy288千赢国际案例-金融数据分析点评

    金融行业qy288千赢国际案例-金融数据分析点评

    Comments on financial figures for Sep 2013 –incremental credit beats expectations but bill financing declines At

    read more